Nearly 200 cases in more than 20 countries, according to WHO
The World Health Organization (WHO) said Friday that nearly 200 cases of monkeypox have been reported in more than 20 countries that are not generally known to have outbreaks of the unusual disease. The UN agency called the outbreak “controllable” and offered to create a stockpile to fairly share the limited vaccines and medicines available around the world, says an Associated Press report.
“We believe that if we put the right measures in place now, we can probably contain this easily,” said Sylvie Briand, WHO director for global infectious risk preparedness, at the agency’s annual meeting. United Nations.
Read also: Explanation: Should you be worried about monkeypox?
According Reuters health bulletin, the US Centers for Disease Control and Prevention (CDC) on Friday released recommendations from its independent expert panel on a smallpox vaccine that limit its use only to people who work closely with viruses such as monkeypox. The Jynneos vaccine, made by Bavarian Nordic, will be available to some healthcare workers and lab staff at a time when monkeypox infections have spread across Europe, the United States and beyond.
Officials said there were more than 100 million doses of an old smallpox vaccine called ACAM2000, made by Emergent BioSolutions, which has significant side effects, a Reuters copy adds.
Global health authorities are concerned because the recent outbreaks reported so far are atypical, occurring in countries where the virus does not regularly circulate. Scientists seek to understand the origin of the current cases and if anything about the virus has changed, an earlier Reuters copy explained.
Additionally, Argentina confirmed the first two cases of monkeypox in Latin America on Friday, the health ministry said in statements. Spain, England and Portugal are the countries that have recorded the most cases during the recent outbreak of this usually mild viral illness outside of their endemic areas, which are normally found in parts of West and Central Africa.
The outbreak, unsurprisingly, has also led to the spread of new misinformation about monkeypox and covid-19 vaccines. On Friday, May 27, The Associated Press reported on stories circulating online that falsely claim that the chimpanzee adenovirus vector used in AstraZeneca’s COVID-19 vaccine is the source of the monkeypox outbreak.
Adenoviruses and poxviruses are not related, and monkeys and chimpanzees are different species. While the AstraZeneca COVID-19 vaccine uses a harmless, weakened chimpanzee adenovirus to trigger an immune response, the strain has been modified so that it cannot infect humans or cause monkeypox, says a report from the ‘AP.
Read also: Can this new nanotechnology tool accelerate the manufacture of vaccines?
(With contributions from Reuters and AP)